Taspoglutide
A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy
Roche · Phase 3 · Completed · Enrollment 305
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| placebo | n/r | n/r | n/r | n/r | n/r |
| taspoglutide | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.